Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Aabha Oza; Michael P. Rettig; Phil Powell; Kathryn O'Brien; David B. Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A. Fehniger; Christopher A. Miller; Patrick Soon-Shiong; Amy Rock; John F. DiPersio

doi:10.1182/bloodadvances.2019000664

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Aabha Oza
, Michael P. Rettig
, Phil Powell
, Kathryn O'Brien
, David B. Clifford
, Julie Ritchey
, Leah Gehrs
, Julia Hollaway
, Eugene Major
, Todd A. Fehniger
, Christopher A. Miller
, Patrick Soon-Shiong
, Amy Rock
, John F. DiPersio

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2387-2391
Number of pages	5
Journal	Blood Advances
Volume	4
Issue number	11
DOIs	https://doi.org/10.1182/bloodadvances.2019000664
State	Published - Jun 9 2020

Access to Document

10.1182/bloodadvances.2019000664

Cite this

Oza, A., Rettig, M. P., Powell, P., O'Brien, K., Clifford, D. B., Ritchey, J., Gehrs, L., Hollaway, J., Major, E., Fehniger, T. A., Miller, C. A., Soon-Shiong, P., Rock, A., & DiPersio, J. F. (2020). Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. Blood Advances, 4(11), 2387-2391. https://doi.org/10.1182/bloodadvances.2019000664

@article{11ea2330174a4dab874a892ad3613aa7,

title = "Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient",

author = "Aabha Oza and Rettig, \{Michael P.\} and Phil Powell and Kathryn O'Brien and Clifford, \{David B.\} and Julie Ritchey and Leah Gehrs and Julia Hollaway and Eugene Major and Fehniger, \{Todd A.\} and Miller, \{Christopher A.\} and Patrick Soon-Shiong and Amy Rock and DiPersio, \{John F.\}",

note = "Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA091842).",

year = "2020",

month = jun,

day = "9",

doi = "10.1182/bloodadvances.2019000664",

language = "English",

volume = "4",

pages = "2387--2391",

journal = "Blood Advances",

issn = "2473-9529",

number = "11",

}

Oza, A, Rettig, MP, Powell, P, O'Brien, K, Clifford, DB, Ritchey, J, Gehrs, L, Hollaway, J, Major, E, Fehniger, TA , Miller, CA, Soon-Shiong, P, Rock, A & DiPersio, JF 2020, 'Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient', Blood Advances, vol. 4, no. 11, pp. 2387-2391. https://doi.org/10.1182/bloodadvances.2019000664

TY - JOUR

T1 - Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

AU - Oza, Aabha

AU - Rettig, Michael P.

AU - Powell, Phil

AU - O'Brien, Kathryn

AU - Clifford, David B.

AU - Ritchey, Julie

AU - Gehrs, Leah

AU - Hollaway, Julia

AU - Major, Eugene

AU - Fehniger, Todd A.

AU - Miller, Christopher A.

AU - Soon-Shiong, Patrick

AU - Rock, Amy

AU - DiPersio, John F.

N1 - Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA091842).

PY - 2020/6/9

Y1 - 2020/6/9

UR - https://www.scopus.com/pages/publications/85088408636

U2 - 10.1182/bloodadvances.2019000664

DO - 10.1182/bloodadvances.2019000664

M3 - Article

C2 - 32484854

AN - SCOPUS:85088408636

SN - 2473-9529

VL - 4

SP - 2387

EP - 2391

JO - Blood Advances

JF - Blood Advances

IS - 11

ER -

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Access to Document

Other files and links

Cite this